# FDA Inspection 1005192 - Grifols Biomat USA, Inc. - March 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/grifols-biomat-usa-inc/bc7f829b-1975-4430-981c-3f668acef968
Source feed: FDA_Inspections

> FDA Inspection 1005192 for Grifols Biomat USA, Inc. on March 15, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1005192
- Company Name: Grifols Biomat USA, Inc.
- Inspection Date: 2017-03-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1190557 - 2022-11-09](https://www.keypedia.com/records/fda_inspections/grifols-biomat-usa-inc/d79c2ce6-9b17-46d8-9b0f-c65c23b90905)
- [FDA Inspection 1190557 - 2022-11-09](https://www.keypedia.com/records/fda_inspections/grifols-biomat-usa-inc/7fdee02f-ab3a-4416-89d6-0346f6d8a68e)
- [FDA Inspection 753748 - 2011-11-15](https://www.keypedia.com/records/fda_inspections/grifols-biomat-usa-inc/a68e5ac0-5a18-4af3-8b8a-0feff7260c3f)

Company: https://www.keypedia.com/companies/grifols-biomat-usa-inc/9898367c-44d4-4217-af0a-8fa0ca133eb7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d